Peter Rohdewald
Impact in
- Biochemistry top 0.5%
- Phytochemicals and Antioxidant Activities
- Antioxidant Activity and Oxidative Stress
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Advanced Drug Delivery Systems 6
- Co-authors
- Petra HöggerGudrun WürthweinHartmut DerendorfFrank SchönlauH MöllmannRonald R. WatsonMohamed S. El-SamaligyDavid F. Fitzpatrick
- Journals
- Phytotherapy Research (9 papers)Pharmaceutical Research (6 papers)Biopharmaceutics & Drug Disposition (4 papers)Journal of Pharmacy and Pharmacology (4 papers)International Journal of Pharmaceutics (3 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Peter Rohdewald
109 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 136
- Biochemistry 701
- Internal Medicine 164
- Complementary and alternative medicine 329
- Pharmaceutical Science 195
- Endocrinology, Diabetes and Metabolism 512
Countries citing papers authored by Peter Rohdewald
This map shows the geographic impact of Peter Rohdewald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Rohdewald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Rohdewald more than expected).
Fields of papers citing papers by Peter Rohdewald
This network shows the impact of papers produced by Peter Rohdewald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Rohdewald. The network helps show where Peter Rohdewald may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Rohdewald, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 10 | |
| 2 | 2009 | 0 | |
| 3 | 2009 | 25 | |
| 4 | 2008 | 89 | |
| 5 | 2008 | 37 | |
| 6 | 2008 | 15 | |
| 7 | 2006 | 33 | |
| 8 | 2004 | 93 | |
| 9 | 2002 | 396 | |
| 10 | 2000 | 17 | |
| 11 | 1998 | 124 | |
| 12 | 1994 | 3 | |
| 13 | 1993 | 21 | |
| 14 | 1989 | 2 | |
| 15 | 1988 | 23 | |
| 16 | 1988 | 21 | |
| 17 | 1985 | 13 | |
| 18 | 1985 | 8 | |
| 19 | 1984 | 1 | |
| 20 | 1984 | 1 |
About Peter Rohdewald
Peter Rohdewald is a scholar working on Internal Medicine, Pharmaceutical Science, Biochemistry, Endocrinology, Diabetes and Metabolism and Pharmacology, having authored 110 papers that have together received 3.8k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (10 papers), Pain Mechanisms and Treatments (8 papers), Asthma and respiratory diseases (8 papers), Analytical Methods in Pharmaceuticals (7 papers), Inhalation and Respiratory Drug Delivery (7 papers), Diagnosis and Treatment of Venous Diseases (7 papers), Advanced Drug Delivery Systems (6 papers) and Phytochemicals and Antioxidant Activities (6 papers). The work is most often cited by research in Biochemistry (701 citations), Internal Medicine (164 citations), Complementary and alternative medicine (329 citations), Pharmaceutical Science (195 citations) and Endocrinology, Diabetes and Metabolism (512 citations). Peter Rohdewald has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Petra Högger, Gudrun Würthwein, Hartmut Derendorf, Frank Schönlau, H Möllmann, Ronald R. Watson, Mohamed S. El-Samaligy, David F. Fitzpatrick, Annett Schwarz and Mark Dugall. Their work appears in journals such as Phytotherapy Research, Pharmaceutical Research, Biopharmaceutics & Drug Disposition, Journal of Pharmacy and Pharmacology and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.